Furthermore, there is limited literature on the expression of BCMA in the circulating cells of patients with hematological malignancies and, to the best of our knowledge, BCMA has not been used as a marker for the detection or isolation of circulating malignant PCs. The gene discussed is TNFRSF17; the disease is hematologic disorder.